bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · Real-Time Price · USD
0.293
-0.010 (-3.27%)
Nov 21, 2024, 1:08 PM EST - Market open
bluebird bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 52.93 | 29.07 | 2.74 | 2.85 | - | - | Upgrade
|
| Other Revenue | 0.2 | 0.43 | 0.86 | 0.81 | - | - | Upgrade
|
| Revenue | 53.12 | 29.5 | 3.6 | 3.66 | - | - | Upgrade
|
| Revenue Growth (YoY) | 144.50% | 720.04% | -1.77% | - | - | - | Upgrade
|
| Cost of Revenue | 78.78 | 33.53 | 10.08 | 354.8 | 319.31 | 327.12 | Upgrade
|
| Gross Profit | -25.66 | -4.03 | -6.48 | -351.14 | -319.31 | -327.12 | Upgrade
|
| Selling, General & Admin | 205.19 | 190.38 | 169.47 | 209.97 | 239.95 | 235.84 | Upgrade
|
| Research & Development | 87.63 | 142.79 | 171.3 | - | - | - | Upgrade
|
| Other Operating Expenses | - | -92.93 | -102 | - | - | - | Upgrade
|
| Operating Expenses | 292.81 | 240.23 | 238.77 | 209.97 | 239.95 | 235.84 | Upgrade
|
| Operating Income | -318.48 | -244.26 | -245.25 | -561.11 | -559.26 | -562.96 | Upgrade
|
| Interest Expense | -20.9 | -16.35 | -6.32 | - | - | - | Upgrade
|
| Interest & Investment Income | 8.96 | 9.87 | 1.03 | 0.88 | 5.77 | 17.38 | Upgrade
|
| Other Non Operating Income (Expenses) | 40.31 | 38.71 | 28.39 | -1.7 | 0.34 | -0.69 | Upgrade
|
| EBT Excluding Unusual Items | -290.1 | -212.04 | -222.15 | -561.93 | -553.15 | -546.27 | Upgrade
|
| Merger & Restructuring Charges | -2.81 | - | -4.94 | -29.81 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -3.14 | 29.36 | -7.22 | -9.3 | Upgrade
|
| Pretax Income | -292.91 | -212.04 | -230.23 | -562.38 | -560.37 | -555.57 | Upgrade
|
| Income Tax Expense | -0.08 | -0.13 | 0.12 | 0.26 | 0.69 | -0.55 | Upgrade
|
| Earnings From Continuing Operations | -292.83 | -211.91 | -230.34 | -562.64 | -561.06 | -555.02 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | -256.74 | -57.64 | -234.59 | Upgrade
|
| Net Income | -292.83 | -211.91 | -230.34 | -819.38 | -618.7 | -789.61 | Upgrade
|
| Net Income to Common | -292.83 | -211.91 | -230.34 | -819.38 | -618.7 | -789.61 | Upgrade
|
| Shares Outstanding (Basic) | 175 | 110 | 79 | 69 | 62 | 55 | Upgrade
|
| Shares Outstanding (Diluted) | 175 | 110 | 79 | 69 | 62 | 55 | Upgrade
|
| Shares Change (YoY) | 72.23% | 39.75% | 14.04% | 10.83% | 12.66% | 6.07% | Upgrade
|
| EPS (Basic) | -1.67 | -1.93 | -2.93 | -11.89 | -9.95 | -14.31 | Upgrade
|
| EPS (Diluted) | -1.68 | -1.93 | -2.93 | -11.89 | -9.95 | -14.31 | Upgrade
|
| Free Cash Flow | -267.32 | -239.24 | -324.43 | -650.14 | -499.34 | -635.41 | Upgrade
|
| Free Cash Flow Per Share | -1.53 | -2.18 | -4.13 | -9.43 | -8.03 | -11.51 | Upgrade
|
| Gross Margin | -48.31% | -13.66% | -180.15% | - | - | - | Upgrade
|
| Operating Margin | -599.54% | -828.09% | -6818.04% | -15322.36% | - | - | Upgrade
|
| Profit Margin | -551.25% | -718.42% | -6403.73% | -22375.15% | - | - | Upgrade
|
| Free Cash Flow Margin | -503.24% | -811.05% | -9019.38% | -17753.74% | - | - | Upgrade
|
| EBITDA | -262.27 | -215.74 | -236.9 | -555.65 | -553.63 | -558.52 | Upgrade
|
| D&A For EBITDA | 56.2 | 28.53 | 8.34 | 5.45 | 5.63 | 4.44 | Upgrade
|
| EBIT | -318.48 | -244.26 | -245.25 | -561.11 | -559.26 | -562.96 | Upgrade
|
| Revenue as Reported | 53.12 | 29.5 | 3.6 | 3.66 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.